Parexel International Corp (PRXL)

68.69
0.75 1.10
NASDAQ : Health Care
Prev Close 67.94
Open 67.82
Day Low/High 67.82 / 69.02
52 Wk Low/High 56.00 / 73.62
Volume 237.00K
Avg Volume 396.40K
Exchange NASDAQ
Shares Outstanding 52.89M
Market Cap 3.60B
EPS 2.90
P/E Ratio 25.71
Div & Yield N.A. (N.A)

Latest News

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review...

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Here are Monday's top research calls, including upgrades for Groupon and Humana, and downgrades for Monster Beverage and Merck.

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for Fourth Quarter and Fiscal Year 2016 on Wednesday, August 3, 2016 after the close of the stock market.

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

The sharp declines seen across the healthcare sector could present buying opportunities in companies such as Aetna, HCA, Icon and Paraxel.

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2016

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2016

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52 nd Annual Drug...

PAREXEL Invites Public To Listen To Live Webcast Of Investor Day Presentations On June 30

PAREXEL Invites Public To Listen To Live Webcast Of Investor Day Presentations On June 30

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from...

PAREXEL Announces Master Services Agreement With Pfizer

PAREXEL Announces Master Services Agreement With Pfizer

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc.

PAREXEL Named Company Of The Year For The Pharmaceuticals Industry With A Gold Stevie From The American Business Awards

PAREXEL Named Company Of The Year For The Pharmaceuticals Industry With A Gold Stevie From The American Business Awards

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year - Pharmaceuticals in the 14 th Annual American Business Awards SM.

PAREXEL International To Present At Goldman Sachs Global Healthcare Conference And Jefferies Healthcare Conference

PAREXEL International To Present At Goldman Sachs Global Healthcare Conference And Jefferies Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.

PAREXEL International To Present At UBS Healthcare Conference

PAREXEL International To Present At UBS Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City.

PAREXEL International Reports Third Quarter Fiscal Year 2016 Results

PAREXEL International Reports Third Quarter Fiscal Year 2016 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2016, which ended on March 31, 2016.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

PAREXEL International To Present At Deutsche Bank Healthcare Conference

PAREXEL International To Present At Deutsche Bank Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will present at the Deutsche Bank 41st Annual Health Care Conference in Boston.

PAREXEL And EMC Form Alliance To Provide Cloud-Based Document And Regulatory Information Management Services

PAREXEL And EMC Form Alliance To Provide Cloud-Based Document And Regulatory Information Management Services

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, and EMC Corporation (NYSE: EMC) today announced they have entered into an alliance to offer an end-to-end...

14 Cheap Stocks to Buy Now From Goldman Sachs

14 Cheap Stocks to Buy Now From Goldman Sachs

These 14 inexpensive stocks are expected to have strong top-line growth in the next two years, says Goldman Sachs.

Insider Trading Alert - O, PRXL And CNBKA Traded By Insiders

Insider Trading Alert - O, PRXL And CNBKA Traded By Insiders

Stocks with insider trader activity include O, PRXL and CNBKA

PAREXEL International Announces Date Of Third Quarter Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Announces Date Of Third Quarter Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2016 on Wednesday, April 27 th, 2016 after the close of the stock market.

PAREXEL Named To The 2016 Forbes America's Best Employers List

PAREXEL Named To The 2016 Forbes America's Best Employers List

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that Forbes named the Company to the magazine's America's "Best Employers" list for 2016.

Insider Trading Alert - TREX, PRXL And ARE Traded By Insiders

Insider Trading Alert - TREX, PRXL And ARE Traded By Insiders

Stocks with insider trader activity include TREX, PRXL and ARE

PAREXEL International To Present At Barclay's Global Healthcare Conference

PAREXEL International To Present At Barclay's Global Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Barclay's Global Healthcare Conference on Thursday, March 17, 2016, in Miami.

Parexel Named A FlexJobs Top 100 Company To Watch For Telecommuting Jobs In 2016

Parexel Named A FlexJobs Top 100 Company To Watch For Telecommuting Jobs In 2016

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting Jobs in 2016...

PAREXEL Launches Expanded Genomic Research Services

PAREXEL Launches Expanded Genomic Research Services

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced expanded services and capabilities in genomic-based drug development.

Parexel International (PRXL) Is Water-Logged And Getting Wetter Today

Parexel International (PRXL) Is Water-Logged And Getting Wetter Today

Trade-Ideas LLC identified Parexel International (PRXL) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Trade-Ideas: Parexel International (PRXL) Is Today's Post-Market Leader Stock

Trade-Ideas: Parexel International (PRXL) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Parexel International (PRXL) as a post-market leader candidate

PAREXEL International Reports Second Quarter Fiscal Year 2016 Results

PAREXEL International Reports Second Quarter Fiscal Year 2016 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2016, which ended on December 31, 2015.

Optum And PAREXEL To Accelerate Drug Development, Reimbursement And Market Access With EHR-Fueled Clinical Research And Hybrid Studies

Optum And PAREXEL To Accelerate Drug Development, Reimbursement And Market Access With EHR-Fueled Clinical Research And Hybrid Studies

Optum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further...

PAREXEL Announces Execution Of Definitive Agreement To Acquire Health Advances

PAREXEL Announces Execution Of Definitive Agreement To Acquire Health Advances

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that the Company has entered into a definitive agreement to acquire all outstanding equity...

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International To Present At JP Morgan Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco.